Vivos Therapeutics, Inc. (VVOS) has a market capitalization of $7.95M and trades at $1.35. The 52-week range is 1.085-7.95.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.8, Earnings Per Share (EPS) of $-1.68, annual revenue of $15.03M.
The stock has a beta of 6.90, operates in the Healthcare sector.
